Status: Recruiting
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
Th purpose of the study is to evaluate the dose response of WD-890 in efficacy at Week 16 in participants with moderate-to-severe plaque psoriasis.
Participants needed: 140
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Zhejiang Wenda Pharma Technology LTD.Updated: Apr 11, 2025Locations: 1
Eligibility criteria
Male or female participant aged 18 to 70 years(inclusive)at the time of informed... [+2]
Participant has a nonplaque form of psoriasis (for example, erythrodermic, gutta... [+3]